查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2007793

合成生物學平台市場預測至2034年—按類型、應用、最終用戶和地區分類的全球分析

Synthetic Biology Platforms Market Forecasts to 2034- Global Analysis By Type (DNA Synthesis Platforms, Gene Editing Platforms, Protein Engineering Platforms and Metabolic Engineering Platforms), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球合成生物學平台市場規模將達到 61.8 億美元，在預測期內複合年成長率將達到 22.8%，到 2034 年將達到 320 億美元。

合成生物學平台是一個整合了技術和計算科學的框架，旨在實現用於工業、醫療和環境應用的生物系統的設計、建構和最佳化。這些平台結合了基因工程、高通量篩檢、自動化和生物資訊學，能夠高精度、高效地創造新型生物體並改造現有生物體。透過快速原型製作基因迴路、代謝路徑和生物分子原型，合成生物學平台加速了藥物研發、農業、生質燃料和診斷領域的創新。其擴充性、模組化和可程式設計確保了實驗的可重複性，降低了實驗成本，並促進了從傳統生物學轉向設計型生物解決方案的轉變。

對先進生物製藥的需求不斷成長

全球對創新生物製藥日益成長的需求正在推動合成生物學平台的發展。隨著精準醫療、基因療法和個人化生物製藥的興起，企業需要能夠高效設計和最佳化複雜生物系統的整合平台。這些平台能夠加速藥物發現進程、縮短研發週期並提高可重複性，從而滿足人們對更安全、更有效療法的日益成長的需求。因此，對先進生物製藥的需求成為主要的成長要素，而合成生物學平台正逐漸成為生命科學領域不可或缺的工具。

監管複雜性和生物安全問題

儘管技術不斷進步，合成生物學平台仍面臨來自法律規範和生物安全要求的重大挑戰。基因改造、環境釋放和臨床應用均有嚴格的指導方針，這往往導致研究和商業化進程的延遲。倫理考量、對生態系統的意外影響以及實驗室安全問題進一步加劇了其應用推廣的複雜性。合規需要大量的文件記錄、測試和監測，這增加了操作的複雜性。這些監管和生物安全障礙是限制市場滲透的主要阻礙因素。

工具和平台的技術進步

基因編輯、自動化、高通量篩檢和生物資訊學領域的持續創新為合成生物學平台帶來了巨大的機會。基於CRISPR的新型工具和可擴展的生物反應器提高了生物技術的精確性和可重複性。這些進步加速了基因迴路和生物分子的原型製作，使其能夠應用於製藥、農業和環境解決方案等領域。隨著技術的不斷發展，平台變得更加模組化和易於使用，從而開拓了新的市場，並加速了其在生物技術、學術研究和產業界的普及應用。

高昂的初始成本和技術壁壘

建構合成生物學平台需要對先進的實驗室基礎設施和專用軟體進行大量資金投入。此外，其技術複雜性要求具備設計、建模和建構人工生物系統能力的高技能人才。這些高昂的初始成本和知識門檻對中小企業而言構成了特別重大的准入障礙。此外，系統整合挑戰、維護需求以及人才培養需求仍然是持續存在的難題，而高昂的成本和技術要求也對合成生物學平台的廣泛應用構成了重大威脅。

新冠疫情的感染疾病：

新冠疫情凸顯了快速生物技術創新的重要性，並加速了人們對合成生物學平台的關注。這些平台透過高通量篩檢和基因工程加速了疫苗、治療藥物和診斷工具的研發。然而，供應鏈中斷、實驗室進入受限以及研究重點的調整暫時影響了研發進度。儘管面臨這些挑戰，疫情也凸顯了擴充性和自動化平台的戰略價值，促使人們加強長期投資並提高認知度。

在預測期內，生技公司細分市場預計將佔據最大的市場佔有率。

由於藥物發現和生物製造領域先進工具的廣泛應用，預計生物技術公司將在預測期內佔據最大的市場佔有率。這些公司利用整合平台最佳化基因迴路、擴大生產規模並加速創新流程。它們強大的研發基礎設施、分子生物學專業知識以及對個人化醫療的專注，使其能夠開發出高價值的應用。因此，生物技術公司保持領先的市場佔有率，並推動平台在製藥和工業生物技術領域的應用。

在預測期內，基因編輯平台領域預計將呈現最高的複合年成長率。

在預測期內，基因編輯平台領域預計將呈現最高的成長率。這是因為整合了CRISPR和其他編輯技術的平台能夠精確修改DNA序列，進而加速藥物研發、農業和合成生物學領域的創新。個人化醫療、功能基因組學研究和工業生物技術等領域對基因編輯平台應用的日益成長的需求，是推動這一成長的主要動力。隨著技術能力的提升，基因編輯平台將提供可重複的解決方案，使其成為整個合成生物學生態系統中成長最快的領域。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其強大的生物技術生態系統、雄厚的研發投入以及政府的支持政策。主要企業的製藥和生物技術公司、一流的研究機構以及完善的法規結構，都促進了相關技術的早期應用。基因組學、合成生物學和精準醫療領域的大量資金投入，正在加速創新。此外，學術機構和政府機構之間的合作正在推動平台開發，使北美成為區域市場的主導力量。

複合年成長率最高的地區：

在預測期內，由於政府對創新支持力度的加大，亞太地區預計將呈現最高的複合年成長率。合成生物學平台正在新興市場迅速應用於藥物研發、農業和工業生物技術等領域。精準醫療意識的不斷提高，加上熟練研究人員數量的成長和成本優勢，正在推動市場擴張。當地企業企業與全球企業之間的技術合作與夥伴關係進一步加速了合成生物學平台的應用，使亞太地區成為成長最快的區域市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章 全球合成生物學平台市場：按類型分類

  • DNA合成平台
  • 基因編輯平台
    • CRISPR
    • TALEN
    • ZFN
  • 蛋白質工程平台
  • 代謝工程平台

第6章 全球合成生物學平台市場：依應用分類

  • 醫療和藥品
    • 藥物發現
    • 基因治療
  • 工業生物技術
    • 生質燃料
    • 生質塑膠
  • 農業和食品
    • 作物改良
    • 合成食品
  • 環境應用
    • 生物修復
    • 生物感測器

第7章 全球合成生物學平台市場：依最終用戶分類

  • 學術研究機構
  • 生技公司
  • 製藥公司
  • 政府和監管機構

第8章 全球合成生物學平台市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第9章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第10章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第11章：公司簡介

  • Ginkgo Bioworks
  • Twist Bioscience
  • Amyris
  • Zymergen
  • Precigen
  • Genomatica
  • Codexis
  • Arzeda
  • Evolva
  • Novozymes
  • Thermo Fisher Scientific
  • Agilent Technologies
  • GenScript Biotech Corporation
  • Integrated DNA Technologies
  • Eurofins Scientific
Product Code: SMRC34665

According to Stratistics MRC, the Global Synthetic Biology Platforms Market is accounted for $6.18 billion in 2026 and is expected to reach $32.0 billion by 2034 growing at a CAGR of 22.8% during the forecast period. Synthetic Biology Platforms are integrated technological and computational frameworks that enable the design, construction, and optimization of biological systems for industrial, medical, and environmental applications. These platforms combine genetic engineering, high-throughput screening, automation, and bioinformatics to create novel organisms or modify existing ones with precision and efficiency. By facilitating rapid prototyping of genetic circuits, metabolic pathways, and biomolecules, synthetic biology platforms accelerate innovation in drug development, agriculture, biofuels, and diagnostics. Their scalable, modular, and programmable nature ensures reproducibility, reduces experimental costs, and drives the transition from traditional biology to engineered biological solutions.

Market Dynamics:

Driver:

Rising Demand for Advanced Biopharmaceuticals

The global push for innovative biopharmaceuticals is fueling the growth of synthetic biology platforms. As precision medicine, gene therapies, and personalized biologics gain prominence, companies require integrated platforms capable of designing and optimizing complex biological systems efficiently. These platforms accelerate drug discovery, reduce development timelines, and enhance reproducibility, meeting the increasing demand for safer, effective therapeutics. Consequently, the need for advanced biopharmaceuticals acts as a primary growth driver, positioning synthetic biology platforms as essential tools across the life sciences sector.

Restraint:

Regulatory Complexity and Biosafety Concerns

Despite technological advancements, synthetic biology platforms face significant challenges from regulatory frameworks and biosafety requirements. Stringent guidelines govern genetic modifications, environmental release, and clinical applications, often leading to delays in research and commercialization. Concerns around ethical considerations, unintended ecological impacts, and laboratory safety further complicate adoption. Compliance demands extensive documentation, testing, and oversight, increasing operational complexity. These regulatory and biosafety hurdles act as a major restraint, limiting market penetration.

Opportunity:

Technological Advancements in Tools and Platforms

Continuous innovation in gene editing, automation, high throughput screening, and bioinformatics presents immense opportunities for synthetic biology platforms. Novel CRISPR-based tools and scalable bioreactors enhance precision and reproducibility in biological engineering. These advancements allow faster prototyping of genetic circuits and biomolecules, enabling applications in pharmaceuticals, agriculture, and environmental solutions. As technology evolves, platforms become more modular and accessible and opening new markets and accelerating adoption across biotechnology, academic research, and industrial sectors.

Threat:

High Initial Costs and Technical Barriers

The deployment of synthetic biology platforms involves substantial capital investment in advanced laboratory infrastructure and specialized software. Additionally, technical complexity demands highly skilled personnel capable of designing, modeling, and implementing engineered biological systems. These high initial costs and knowledge barriers limit accessibility, particularly for small and mid-sized enterprises. Furthermore, integration challenges, maintenance requirements, and training demands pose ongoing hurdles, making cost and technical expertise critical threats that could impede broader adoption.

Covid-19 Impact:

The Covid-19 pandemic has underscored the importance of rapid biotechnological innovation, accelerating interest in synthetic biology platforms. These platforms enabled faster development of vaccines, therapeutics, and diagnostic tools through high-throughput screening and genetic engineering. However, disruptions in supply chains, laboratory access restrictions, and shifting research priorities temporarily affected R&D timelines. Despite these challenges, the pandemic highlighted the strategic value of scalable, automated platforms, boosting long-term investment and awareness.

The biotechnology companies segment is expected to be the largest during the forecast period

The biotechnology companies segment is expected to account for the largest market share during the forecast period, due to its extensive adoption of advanced tools for drug discovery and biomanufacturing. These companies leverage integrated platforms to optimize genetic circuits, scale up production, and accelerate innovation pipelines. Their robust R&D infrastructure, expertise in molecular biology, and focus on personalized therapeutics enable high-value applications. As a result, biotechnology companies maintain a leading market share, driving platform utilization across pharmaceuticals and industrial biotechnology initiatives.

The gene editing platforms segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the gene editing platforms segment is predicted to witness the highest growth rate, as platforms integrating CRISPR and other editing technologies allow precise modification of DNA sequences, enabling accelerated innovation in drug development, agriculture, and synthetic organisms. The increasing demand for personalized medicine, functional genomics studies, and industrial biotechnology applications fuels growth. As technological capabilities expand, gene editing platforms provide reproducible solutions, positioning this segment as the fastest-growing within the broader synthetic biology ecosystem.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to robust biotechnology ecosystem, strong R&D investment, and supportive government initiatives. The presence of leading pharmaceutical and biotech companies, cutting-edge research institutions, and well-established regulatory frameworks facilitates early adoption. Extensive funding for genomics, synthetic biology, and precision medicine accelerates innovation. Additionally, collaborations between academic and government entities drive platform development, making North America a dominant regional market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to increasing government support for innovation. Emerging economies are rapidly adopting synthetic biology platforms for pharmaceutical development, agriculture, and industrial biotechnology applications. Rising awareness of precision medicine, coupled with a growing pool of skilled researchers and cost advantages, enhances market expansion. Technological collaborations and partnerships between local and global players further accelerate adoption, positioning Asia Pacific as the fastest growing regional market.

Key players in the market

Some of the key players in Synthetic Biology Platforms Market include Ginkgo Bioworks, Twist Bioscience, Amyris, Zymergen, Precigen, Genomatica, Codexis, Arzeda, Evolva, Novozymes, Thermo Fisher Scientific, Agilent Technologies, GenScript Biotech Corporation, Integrated DNA Technologies and Eurofins Scientific.

Key Developments:

In July 2025, Thermo Fisher Scientific and Sanofi have deepened their long-standing alliance as Thermo Fisher acquires Sanofi's sterile drug manufacturing facility in Ridgefield, New Jersey, boosting U.S. drug production capacity and ensuring continued manufacture of key Sanofi therapies under an expanded strategic partnership.

In June 2025, Exum Instruments and Thermo Fisher Scientific have forged a strategic distribution partnership that brings Exum's Massbox(R) elemental analysis technology to Europe and China, leveraging Thermo Fisher's global network to expand access, support researchers, and accelerate materials and battery development workflows.

Types Covered:

  • DNA Synthesis Platforms
  • Gene Editing Platforms
  • Protein Engineering Platforms
  • Metabolic Engineering Platforms

Applications Covered:

  • Healthcare & Pharmaceuticals
  • Industrial Biotechnology
  • Agriculture & Food
  • Environmental Applications

End Users Covered:

  • Academic & Research Institutes
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Government & Regulatory Bodies

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Synthetic Biology Platforms Market, By Type

  • 5.1 DNA Synthesis Platforms
  • 5.2 Gene Editing Platforms
    • 5.2.1 CRISPR
    • 5.2.2 TALEN
    • 5.2.3 ZFN
  • 5.3 Protein Engineering Platforms
  • 5.4 Metabolic Engineering Platforms

6 Global Synthetic Biology Platforms Market, By Application

  • 6.1 Healthcare & Pharmaceuticals
    • 6.1.1 Drug Discovery
    • 6.1.2 Gene Therapy
  • 6.2 Industrial Biotechnology
    • 6.2.1 Biofuels
    • 6.2.2 Bioplastics
  • 6.3 Agriculture & Food
    • 6.3.1 Crop Improvement
    • 6.3.2 Synthetic Foods
  • 6.4 Environmental Applications
    • 6.4.1 Bioremediation
    • 6.4.2 Biosensors

7 Global Synthetic Biology Platforms Market, By End User

  • 7.1 Academic & Research Institutes
  • 7.2 Biotechnology Companies
  • 7.3 Pharmaceutical Companies
  • 7.4 Government & Regulatory Bodies

8 Global Synthetic Biology Platforms Market, By Geography

  • 8.1 North America
    • 8.1.1 United States
    • 8.1.2 Canada
    • 8.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 United Kingdom
    • 8.2.2 Germany
    • 8.2.3 France
    • 8.2.4 Italy
    • 8.2.5 Spain
    • 8.2.6 Netherlands
    • 8.2.7 Belgium
    • 8.2.8 Sweden
    • 8.2.9 Switzerland
    • 8.2.10 Poland
    • 8.2.11 Rest of Europe
  • 8.3 Asia Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 South Korea
    • 8.3.5 Australia
    • 8.3.6 Indonesia
    • 8.3.7 Thailand
    • 8.3.8 Malaysia
    • 8.3.9 Singapore
    • 8.3.10 Vietnam
    • 8.3.11 Rest of Asia Pacific
  • 8.4 South America
    • 8.4.1 Brazil
    • 8.4.2 Argentina
    • 8.4.3 Colombia
    • 8.4.4 Chile
    • 8.4.5 Peru
    • 8.4.6 Rest of South America
  • 8.5 Rest of the World (RoW)
    • 8.5.1 Middle East
      • 8.5.1.1 Saudi Arabia
      • 8.5.1.2 United Arab Emirates
      • 8.5.1.3 Qatar
      • 8.5.1.4 Israel
      • 8.5.1.5 Rest of Middle East
    • 8.5.2 Africa
      • 8.5.2.1 South Africa
      • 8.5.2.2 Egypt
      • 8.5.2.3 Morocco
      • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

  • 9.1 Industry Value Network and Supply Chain Assessment
  • 9.2 White-Space and Opportunity Mapping
  • 9.3 Product Evolution and Market Life Cycle Analysis
  • 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

  • 10.1 Mergers and Acquisitions
  • 10.2 Partnerships, Alliances, and Joint Ventures
  • 10.3 New Product Launches and Certifications
  • 10.4 Capacity Expansion and Investments
  • 10.5 Other Strategic Initiatives

11 Company Profiles

  • 11.1 Ginkgo Bioworks
  • 11.2 Twist Bioscience
  • 11.3 Amyris
  • 11.4 Zymergen
  • 11.5 Precigen
  • 11.6 Genomatica
  • 11.7 Codexis
  • 11.8 Arzeda
  • 11.9 Evolva
  • 11.10 Novozymes
  • 11.11 Thermo Fisher Scientific
  • 11.12 Agilent Technologies
  • 11.13 GenScript Biotech Corporation
  • 11.14 Integrated DNA Technologies
  • 11.15 Eurofins Scientific

List of Tables

  • Table 1 Global Synthetic Biology Platforms Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Synthetic Biology Platforms Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Synthetic Biology Platforms Market Outlook, By DNA Synthesis Platforms (2023-2034) ($MN)
  • Table 4 Global Synthetic Biology Platforms Market Outlook, By Gene Editing Platforms (2023-2034) ($MN)
  • Table 5 Global Synthetic Biology Platforms Market Outlook, By CRISPR (2023-2034) ($MN)
  • Table 6 Global Synthetic Biology Platforms Market Outlook, By TALEN (2023-2034) ($MN)
  • Table 7 Global Synthetic Biology Platforms Market Outlook, By ZFN (2023-2034) ($MN)
  • Table 8 Global Synthetic Biology Platforms Market Outlook, By Protein Engineering Platforms (2023-2034) ($MN)
  • Table 9 Global Synthetic Biology Platforms Market Outlook, By Metabolic Engineering Platforms (2023-2034) ($MN)
  • Table 10 Global Synthetic Biology Platforms Market Outlook, By Application (2023-2034) ($MN)
  • Table 11 Global Synthetic Biology Platforms Market Outlook, By Healthcare & Pharmaceuticals (2023-2034) ($MN)
  • Table 12 Global Synthetic Biology Platforms Market Outlook, By Drug Discovery (2023-2034) ($MN)
  • Table 13 Global Synthetic Biology Platforms Market Outlook, By Gene Therapy (2023-2034) ($MN)
  • Table 14 Global Synthetic Biology Platforms Market Outlook, By Industrial Biotechnology (2023-2034) ($MN)
  • Table 15 Global Synthetic Biology Platforms Market Outlook, By Biofuels (2023-2034) ($MN)
  • Table 16 Global Synthetic Biology Platforms Market Outlook, By Bioplastics (2023-2034) ($MN)
  • Table 17 Global Synthetic Biology Platforms Market Outlook, By Agriculture & Food (2023-2034) ($MN)
  • Table 18 Global Synthetic Biology Platforms Market Outlook, By Crop Improvement (2023-2034) ($MN)
  • Table 19 Global Synthetic Biology Platforms Market Outlook, By Synthetic Foods (2023-2034) ($MN)
  • Table 20 Global Synthetic Biology Platforms Market Outlook, By Environmental Applications (2023-2034) ($MN)
  • Table 21 Global Synthetic Biology Platforms Market Outlook, By Bioremediation (2023-2034) ($MN)
  • Table 22 Global Synthetic Biology Platforms Market Outlook, By Biosensors (2023-2034) ($MN)
  • Table 23 Global Synthetic Biology Platforms Market Outlook, By End User (2023-2034) ($MN)
  • Table 24 Global Synthetic Biology Platforms Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 25 Global Synthetic Biology Platforms Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 26 Global Synthetic Biology Platforms Market Outlook, By Pharmaceutical Companies (2023-2034) ($MN)
  • Table 27 Global Synthetic Biology Platforms Market Outlook, By Government & Regulatory Bodies (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.